COMPOSÉ DE PYRIDAZINONE SUBSTITUÉ
- 专利权人:
- Shenzhen TargetRx; Inc.
- 发明人:
- 申请号：
- EP19744170.2
- 公开号：
- EP3725779A1
- 申请日:
- 2019.01.17
- 申请国别(地区):
- EP
- 年份:
- 2020
- 代理人:
- 摘要：
- The present invention relates to a pharmaceutical composition of a substituted pyridazinone compound and use thereof. The substituted pyridazinone compound is a compound as represented by formula (I), or a pharmaceutically acceptable salt, a prodrug, a hydrate or solvent compound, a crystalline form, and a stereoisomer or isotopic variant thereof. The compound is a THR-beta agonist which can be used for treating and/or preventing diseases regulated by thyroid hormone analogues.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Use of adrenergic beta-3-receptor agonists in anti-aging
- Adrenergic beta-3-receptor agonists for use in treatment of aging-related diseases
- pharmaceutical preparation, medicament, process for producing said medicament and use of a combination of loteprednol and beta 2 adrenoreceptor agonists.
- Compounds derived from cyclohexylamine, beta2 agonists and antagonists of Muscarinic m3 intermediaries； Compounds； Pharmaceutical composition that comprises； a method for treating Physiological condition or illness； and combination Product comprising the compound and a corticosteroid or an I Nhiidor PDE4.
- Compounds derived from cyclohexylamine, beta2 agonists and antagonists of Muscarinic m3； Intermediate Compounds, Pharmaceutical Composition and Method for treating Physiological condition or illness； and combination Product comprising the composition and a corticosteroid or inhiidor PDE4.
